MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression
International Journal of Molecular Sciences · 25.05.2023 · 24 (11) · 9239
DOI: 10.3390/ijms24119239 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.05.2023. Verfasst von Chiara Compagnoni und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Non-alcoholic Fatty Liver Disease, Liver Neoplasms, MicroRNAs. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DISCAB GRANT 2022, DISCAB GRANT 2023, MIUR-FIRB.
Abstract (Originalsprache)
Non-alcoholic fatty liver disease (NAFLD) is considered a relevant liver chronic disease. Variable percentages of NAFLD cases progress from steatosis to steatohepatitis (NASH), cirrhosis and, eventually, hepatocellular carcinoma (HCC). In this study, we aimed to deepen our understanding of expression levels and functional relationships between miR-182-5p and Cyld-Foxo1 in hepatic tissues from C57BL/6J mouse models of diet-induced NAFL/NASH/HCC progression. A miR-182-5p increase was detected early in livers as NAFLD damage progressed, and in tumors compared to peritumor normal tissues. An in vitro assay on HepG2 cells confirmed Cyld and Foxo1, both tumor-suppressor, as miR-182-5p target genes. According to miR-182-5p expression, decreased protein levels were observed in tumors compared to peritumor tissues. Analysis of miR-182-5p, Cyld and Foxo1 expression levels, based on datasets from human HCC samples, showed results consistent with those from our mouse models, and also highlighted the ability of miR-182-5p to distinguish between normal and tumor tissues (AUC 0.83). Overall, this study shows, for the first time, miR-182-5p overexpression and Cyld-Foxo1 downregulation in hepatic tissues and tumors from a diet-induced NAFLD/HCC mouse model. These data were confirmed by the analysis of datasets from human HCC samples, highlighting miR-182-5p diagnostic accuracy and demonstrating the need for further studies to assess its potential role as a biomarker or therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.
- Center for Molecular Diagnostics and Advanced Therapies, University of L'Aquila, Via Petrini, 67100 L'Aquila, Italy.
ORCID-Profile: Chiara Compagnoni, Davide Vecchiotti, Adriano Angelucci
Förderung
- DISCAB GRANT 2022
- DISCAB GRANT 2023
- MIUR-FIRB
Zitieren
APA
Compagnoni, C., Capelli, R., Zelli, V., Corrente, A., Vecchiotti, D., Flati, I., Di Vito Nolfi, M., Angelucci, A., Alesse, E., Zazzeroni, F., & Tessitore, A. (2023). MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression. International Journal of Molecular Sciences, 24(11), 9239. https://doi.org/10.3390/ijms24119239
Vancouver
Compagnoni C, Capelli R, Zelli V, Corrente A, Vecchiotti D, Flati I, et al. MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression. International Journal of Molecular Sciences. 2023;24(11):9239. doi:10.3390/ijms24119239
BibTeX
@article{Compagnoni2023,
author = {Compagnoni, Chiara and Capelli, Roberta and Zelli, Veronica and Corrente, Alessandra and Vecchiotti, Davide and Flati, Irene and Di Vito Nolfi, Mauro and Angelucci, Adriano and Alesse, Edoardo and Zazzeroni, Francesca and Tessitore, Alessandra},
title = {MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {11},
pages = {9239},
doi = {10.3390/ijms24119239}
}
EUVIMED